Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Scott Lippman
Clinical and Biomarker Outcomes of the Phase II Vandetanib Study From the BATTLE Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
APOBEC-related Mutagenesis and Neo-Peptide Hydrophobicity: Implications for Response to Immunotherapy
OncoImmunology
Oncology
Allergy
Immunology
Related publications
Pharmacogenetic Study of the Impact of ABCB1 Single-Nucleotide Polymorphisms on Lenalidomide Treatment Outcomes in Patients With Multiple Myeloma: Results From a Phase IV Observational Study and Subsequent Phase II Clinical Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase II Cancer Clinical Trials for Biomarker-Guided Treatments
Journal of Biopharmaceutical Statistics
Statistics
Probability
Pharmacology
Cytomegalovirus Vaccine: Phase II Clinical Trial Results
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Phase II Trial of Karenitecin in Patients With Malignant Melanoma: Clinical and Translational Study
Clinical Cancer Research
Cancer Research
Oncology
Treatment–subgroup Interaction: An Example From a Published, Phase II Clinical Trial
Contemporary Clinical Trials
Medicine
Pharmacology
SBRT for Early-Stage Glottic Larynx Cancer—Initial Clinical Outcomes From a Phase I Clinical Trial
PLoS ONE
Multidisciplinary
Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants
Oncologist
Cancer Research
Medicine
Oncology
ERCC1 Is a Prognostic Biomarker in Locally Advanced Head and Neck Cancer: Results From a Randomised, Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
TROG 15.03 Phase II Clinical Trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
BMC Cancer
Cancer Research
Oncology
Genetics
